المؤلفون: Jennifer C.E.Lane, James Weaver, Kristin Kostka, Talita Duarte-Salles, Maria Tereza F. Abrahao, Heba Alghoul, Osaid Alser, Thamir M Alshammari, Patricia Biedermann, Edward Burn, Paula Casajust, Mitch Conover, Aedin C. Culhane, Alexander Davydov, Scott L. DuVall, Dmitry Dymshyts, Sergio Fernandez-Bertolin, Kristina Fišter, Jill Hardin, Laura Hester, George Hripcsak, Seamus Kent, Sajan Khosla, Spyros Kolovos, Christophe G. Lambert, Johan van der Lei, Kristine E. Lynch, Rupa Makadia, Andrea V. Margulis, Michael E. Matheny, Paras Mehta, Daniel R. Morales, Henry Morgan-Stewart, Mees Mosseveld, Danielle Newby, Fredrik Nyberg, Anna Ostropolets, Rae Woong Park, Albert Prats-Uribe, Gowtham A. Rao, Christian Reich, Jenna Reps, Peter Rijnbeek, Selva Muthu Kumaran Sathappan, Martijn Schuemie, Sarah Seager, Anthony Sena, Azza Shoaibi, Matthew Spotnitz, Marc A. Suchard, Joel Swerdel, Carmen O. Torre, David Vizcaya, Haini Wen, Marcel de Wilde, Seng Chan You, Lin Zhang, Oleg Zhuk, Patrick Ryan, Daniel Prieto-Alhambra, OHDSI-COVID-19 consortium

مصطلحات موضوعية: Hydroxychloroquine, Chloroquine, COVID-19, coronavirus, SARS-CoV-2, safety, epidemiology, international, serious adverse event, Rheumatoid Arthritis, Azithromycin

Relation: https://zenodo.org/communities/ehden; https://zenodo.org/communities/ohdsi; https://zenodo.org/communities/eu; https://doi.org/10.1101/2020.04.08.20054551; oai:zenodo.org:4428238

الاتاحة: https://doi.org/10.1101/2020.04.08.20054551